Global Disseminated Intravascular Coagulation Diagnosis Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI04254331

Publication Date:

April 23, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Disseminated Intravascular Coagulation Diagnosis market size is predicted to grow from US$ 626 million in 2025 to US$ 942 million in 2031; it is expected to grow at a CAGR of 7.1% from 2025 to 2031.
Disseminated intravascular coagulation (DIC) is a rare but serious condition that causes abnormal blood clotting throughout the body"s blood vessels. You may develop DIC if you have an infection or injury that affects the body"s normal blood clotting process.DIC is an acquired clinic biological syndrome characterized by widespread coagulation activation, which results in fibrin deposition in the vasculature, organ dysfunction, clotting factor and platelet consumption, and life-threatening hemorrhage. Several underlying disorders can cause disseminated intravascular coagulation (sepsis, cancer, trauma, and pregnancy complicated with eclampsia or other calamities). The cornerstone therapeutic approaches are treating the underlying disease and eliminating the trigger mechanism. DIC-specific therapeutic strategies aim to reduce blood coagulation activation and bleeding risk. Few clinical trials use DIC as an entry criterion.
Disseminated Intravascular Coagulation (DIC) is a complex medical condition characterized by abnormal blood clotting and excessive bleeding. The diagnosis of DIC involves a combination of clinical assessment, laboratory tests, and the identification of underlying causes. Here are some key insights into the global DIC diagnosis market:
Market Outlook: The global DIC diagnosis market is driven by the increasing prevalence of conditions associated with DIC, such as sepsis and cancer. Additionally, advancements in laboratory diagnostics, growing adoption of POCT devices, and the need for timely diagnosis in critical care settings contribute to market growth. Key players in the global DIC diagnosis market include diagnostic companies, pharmaceutical companies, and medical device manufacturers.
Early and accurate diagnosis of DIC is crucial for timely intervention and management. Healthcare professionals must carefully evaluate clinical symptoms, perform appropriate laboratory tests, and identify the underlying causes to diagnose DIC effectively and develop appropriate treatment strategies.
The 鈥淒isseminated Intravascular Coagulation Diagnosis Industry Forecast鈥� looks at past sales and reviews total world Disseminated Intravascular Coagulation Diagnosis sales in 2024, providing a comprehensive analysis by region and market sector of projected Disseminated Intravascular Coagulation Diagnosis sales for 2025 through 2031. With Disseminated Intravascular Coagulation Diagnosis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Disseminated Intravascular Coagulation Diagnosis industry.
This Insight Report provides a comprehensive analysis of the global Disseminated Intravascular Coagulation Diagnosis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Disseminated Intravascular Coagulation Diagnosis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Disseminated Intravascular Coagulation Diagnosis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Disseminated Intravascular Coagulation Diagnosis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Disseminated Intravascular Coagulation Diagnosis.
This report presents a comprehensive overview, market shares, and growth opportunities of Disseminated Intravascular Coagulation Diagnosis market by product type, application, key players and key regions and countries.
Segmentation by Type:
Complete Blood Count with Blood Smear Exam
Partial Thromboplastin Time (PTT)
Prothrombin Time (PT)
Fibrinogen Blood Test
D-dimer Test
Others
Segmentation by Application:
Hospital
Outpatient Center
Diagnostic and Research Laboratories
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
AdvaCare Pharma
Axis-Shield Diagnostics
QuidelOrtho
CTK Biotech
AccuBioTech Co
Getein Biotech
PHC Holdings Corporation
Siemens Healthineers
Eurolyser Diagnostica GmbH

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Disseminated Intravascular Coagulation Diagnosis Market Size (2020-2031)
2.1.2 Disseminated Intravascular Coagulation Diagnosis Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Disseminated Intravascular Coagulation Diagnosis by Country/Region (2020, 2024 & 2031)
2.2 Disseminated Intravascular Coagulation Diagnosis Segment by Type
2.2.1 Complete Blood Count with Blood Smear Exam
2.2.2 Partial Thromboplastin Time (PTT)
2.2.3 Prothrombin Time (PT)
2.2.4 Fibrinogen Blood Test
2.2.5 D-dimer Test
2.2.6 Others
2.3 Disseminated Intravascular Coagulation Diagnosis Market Size by Type
2.3.1 Disseminated Intravascular Coagulation Diagnosis Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Disseminated Intravascular Coagulation Diagnosis Market Size Market Share by Type (2020-2025)
2.4 Disseminated Intravascular Coagulation Diagnosis Segment by Application
2.4.1 Hospital
2.4.2 Outpatient Center
2.4.3 Diagnostic and Research Laboratories
2.4.4 Others
2.5 Disseminated Intravascular Coagulation Diagnosis Market Size by Application
2.5.1 Disseminated Intravascular Coagulation Diagnosis Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Disseminated Intravascular Coagulation Diagnosis Market Size Market Share by Application (2020-2025)
3 Disseminated Intravascular Coagulation Diagnosis Market Size by Player
3.1 Disseminated Intravascular Coagulation Diagnosis Market Size Market Share by Player
3.1.1 Global Disseminated Intravascular Coagulation Diagnosis Revenue by Player (2020-2025)
3.1.2 Global Disseminated Intravascular Coagulation Diagnosis Revenue Market Share by Player (2020-2025)
3.2 Global Disseminated Intravascular Coagulation Diagnosis Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Disseminated Intravascular Coagulation Diagnosis by Region
4.1 Disseminated Intravascular Coagulation Diagnosis Market Size by Region (2020-2025)
4.2 Global Disseminated Intravascular Coagulation Diagnosis Annual Revenue by Country/Region (2020-2025)
4.3 Americas Disseminated Intravascular Coagulation Diagnosis Market Size Growth (2020-2025)
4.4 APAC Disseminated Intravascular Coagulation Diagnosis Market Size Growth (2020-2025)
4.5 Europe Disseminated Intravascular Coagulation Diagnosis Market Size Growth (2020-2025)
4.6 Middle East & Africa Disseminated Intravascular Coagulation Diagnosis Market Size Growth (2020-2025)
5 Americas
5.1 Americas Disseminated Intravascular Coagulation Diagnosis Market Size by Country (2020-2025)
5.2 Americas Disseminated Intravascular Coagulation Diagnosis Market Size by Type (2020-2025)
5.3 Americas Disseminated Intravascular Coagulation Diagnosis Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Disseminated Intravascular Coagulation Diagnosis Market Size by Region (2020-2025)
6.2 APAC Disseminated Intravascular Coagulation Diagnosis Market Size by Type (2020-2025)
6.3 APAC Disseminated Intravascular Coagulation Diagnosis Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Disseminated Intravascular Coagulation Diagnosis Market Size by Country (2020-2025)
7.2 Europe Disseminated Intravascular Coagulation Diagnosis Market Size by Type (2020-2025)
7.3 Europe Disseminated Intravascular Coagulation Diagnosis Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Disseminated Intravascular Coagulation Diagnosis by Region (2020-2025)
8.2 Middle East & Africa Disseminated Intravascular Coagulation Diagnosis Market Size by Type (2020-2025)
8.3 Middle East & Africa Disseminated Intravascular Coagulation Diagnosis Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Disseminated Intravascular Coagulation Diagnosis Market Forecast
10.1 Global Disseminated Intravascular Coagulation Diagnosis Forecast by Region (2026-2031)
10.1.1 Global Disseminated Intravascular Coagulation Diagnosis Forecast by Region (2026-2031)
10.1.2 Americas Disseminated Intravascular Coagulation Diagnosis Forecast
10.1.3 APAC Disseminated Intravascular Coagulation Diagnosis Forecast
10.1.4 Europe Disseminated Intravascular Coagulation Diagnosis Forecast
10.1.5 Middle East & Africa Disseminated Intravascular Coagulation Diagnosis Forecast
10.2 Americas Disseminated Intravascular Coagulation Diagnosis Forecast by Country (2026-2031)
10.2.1 United States Market Disseminated Intravascular Coagulation Diagnosis Forecast
10.2.2 Canada Market Disseminated Intravascular Coagulation Diagnosis Forecast
10.2.3 Mexico Market Disseminated Intravascular Coagulation Diagnosis Forecast
10.2.4 Brazil Market Disseminated Intravascular Coagulation Diagnosis Forecast
10.3 APAC Disseminated Intravascular Coagulation Diagnosis Forecast by Region (2026-2031)
10.3.1 China Disseminated Intravascular Coagulation Diagnosis Market Forecast
10.3.2 Japan Market Disseminated Intravascular Coagulation Diagnosis Forecast
10.3.3 Korea Market Disseminated Intravascular Coagulation Diagnosis Forecast
10.3.4 Southeast Asia Market Disseminated Intravascular Coagulation Diagnosis Forecast
10.3.5 India Market Disseminated Intravascular Coagulation Diagnosis Forecast
10.3.6 Australia Market Disseminated Intravascular Coagulation Diagnosis Forecast
10.4 Europe Disseminated Intravascular Coagulation Diagnosis Forecast by Country (2026-2031)
10.4.1 Germany Market Disseminated Intravascular Coagulation Diagnosis Forecast
10.4.2 France Market Disseminated Intravascular Coagulation Diagnosis Forecast
10.4.3 UK Market Disseminated Intravascular Coagulation Diagnosis Forecast
10.4.4 Italy Market Disseminated Intravascular Coagulation Diagnosis Forecast
10.4.5 Russia Market Disseminated Intravascular Coagulation Diagnosis Forecast
10.5 Middle East & Africa Disseminated Intravascular Coagulation Diagnosis Forecast by Region (2026-2031)
10.5.1 Egypt Market Disseminated Intravascular Coagulation Diagnosis Forecast
10.5.2 South Africa Market Disseminated Intravascular Coagulation Diagnosis Forecast
10.5.3 Israel Market Disseminated Intravascular Coagulation Diagnosis Forecast
10.5.4 Turkey Market Disseminated Intravascular Coagulation Diagnosis Forecast
10.6 Global Disseminated Intravascular Coagulation Diagnosis Forecast by Type (2026-2031)
10.7 Global Disseminated Intravascular Coagulation Diagnosis Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Disseminated Intravascular Coagulation Diagnosis Forecast
11 Key Players Analysis
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Disseminated Intravascular Coagulation Diagnosis Product Offered
11.1.3 Abbott Disseminated Intravascular Coagulation Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 AdvaCare Pharma
11.2.1 AdvaCare Pharma Company Information
11.2.2 AdvaCare Pharma Disseminated Intravascular Coagulation Diagnosis Product Offered
11.2.3 AdvaCare Pharma Disseminated Intravascular Coagulation Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 AdvaCare Pharma Main Business Overview
11.2.5 AdvaCare Pharma Latest Developments
11.3 Axis-Shield Diagnostics
11.3.1 Axis-Shield Diagnostics Company Information
11.3.2 Axis-Shield Diagnostics Disseminated Intravascular Coagulation Diagnosis Product Offered
11.3.3 Axis-Shield Diagnostics Disseminated Intravascular Coagulation Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Axis-Shield Diagnostics Main Business Overview
11.3.5 Axis-Shield Diagnostics Latest Developments
11.4 QuidelOrtho
11.4.1 QuidelOrtho Company Information
11.4.2 QuidelOrtho Disseminated Intravascular Coagulation Diagnosis Product Offered
11.4.3 QuidelOrtho Disseminated Intravascular Coagulation Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 QuidelOrtho Main Business Overview
11.4.5 QuidelOrtho Latest Developments
11.5 CTK Biotech
11.5.1 CTK Biotech Company Information
11.5.2 CTK Biotech Disseminated Intravascular Coagulation Diagnosis Product Offered
11.5.3 CTK Biotech Disseminated Intravascular Coagulation Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 CTK Biotech Main Business Overview
11.5.5 CTK Biotech Latest Developments
11.6 AccuBioTech Co
11.6.1 AccuBioTech Co Company Information
11.6.2 AccuBioTech Co Disseminated Intravascular Coagulation Diagnosis Product Offered
11.6.3 AccuBioTech Co Disseminated Intravascular Coagulation Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 AccuBioTech Co Main Business Overview
11.6.5 AccuBioTech Co Latest Developments
11.7 Getein Biotech
11.7.1 Getein Biotech Company Information
11.7.2 Getein Biotech Disseminated Intravascular Coagulation Diagnosis Product Offered
11.7.3 Getein Biotech Disseminated Intravascular Coagulation Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Getein Biotech Main Business Overview
11.7.5 Getein Biotech Latest Developments
11.8 PHC Holdings Corporation
11.8.1 PHC Holdings Corporation Company Information
11.8.2 PHC Holdings Corporation Disseminated Intravascular Coagulation Diagnosis Product Offered
11.8.3 PHC Holdings Corporation Disseminated Intravascular Coagulation Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 PHC Holdings Corporation Main Business Overview
11.8.5 PHC Holdings Corporation Latest Developments
11.9 Siemens Healthineers
11.9.1 Siemens Healthineers Company Information
11.9.2 Siemens Healthineers Disseminated Intravascular Coagulation Diagnosis Product Offered
11.9.3 Siemens Healthineers Disseminated Intravascular Coagulation Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Siemens Healthineers Main Business Overview
11.9.5 Siemens Healthineers Latest Developments
11.10 Eurolyser Diagnostica GmbH
11.10.1 Eurolyser Diagnostica GmbH Company Information
11.10.2 Eurolyser Diagnostica GmbH Disseminated Intravascular Coagulation Diagnosis Product Offered
11.10.3 Eurolyser Diagnostica GmbH Disseminated Intravascular Coagulation Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Eurolyser Diagnostica GmbH Main Business Overview
11.10.5 Eurolyser Diagnostica GmbH Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂